Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05572229
What this trial is testing

Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Lille 74
Testing effectiveness (Phase 2)Study completedNCT02948829
What this trial is testing

Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

Who this might be right for
Healthy Volunteers
Takeda 200
Testing effectiveness (Phase 2)Study completedNCT02606916
What this trial is testing

Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 42
Testing effectiveness (Phase 2)Study completedNCT00169143
What this trial is testing

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

Who this might be right for
Untreated CD20-positive Large B-cell Lymphoma
Lymphoma Study Association 60
Large-scale testing (Phase 3)Study completedNCT00934154
What this trial is testing

Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cigdem Sahinbas YILMAZ 122
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Post-approval studies (Phase 4)UnknownNCT03971058
What this trial is testing

Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals.

Who this might be right for
Japanese Encephalitis Vaccine
Medical University of Vienna 64
Testing effectiveness (Phase 2)WithdrawnNCT04718467
What this trial is testing

Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention
Large-scale testing (Phase 3)Study completedNCT02623309
What this trial is testing

Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

Who this might be right for
Hematologic Neoplasms
Institut Paoli-Calmettes 108
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Early research (Phase 1)Study completedNCT05762523
What this trial is testing

Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years

Who this might be right for
SmallpoxMonkeypoxCowpox+1 more
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 60
Not applicableStudy completedNCT03429673
What this trial is testing

Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
China-Japan Friendship Hospital 10,885
Large-scale testing (Phase 3)Not Yet RecruitingNCT07611513
What this trial is testing

Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Who this might be right for
Hand, Foot, and Mouth Disease(HFMD)Herpangina
Sinovac Biotech Co., Ltd 6,000
Not applicableStudy completedNCT02265003
What this trial is testing

Red Blood Cells as a Reflection of Endothelial Function in Old Age

Who this might be right for
Red Blood CellsEndothelial FunctionNitric Oxide Pool in Red Blood Cells and Blood Plasma
Heinrich-Heine University, Duesseldorf 140
Testing effectiveness (Phase 2)UnknownNCT00905983
What this trial is testing

Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hospital Arnau de Vilanova 48
Testing effectiveness (Phase 2)WithdrawnNCT02630836
What this trial is testing

Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture

Who this might be right for
Femoral Neck Fracture
Banc de Sang i Teixits
Not applicableStudy completedNCT02355821
What this trial is testing

Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women

Who this might be right for
OsteopeniaArterial Hypertension
National Research Center for Preventive Medicine 114
Early research (Phase 1)Study completedNCT05765604
What this trial is testing

Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 72
Testing effectiveness (Phase 2)UnknownNCT01181999
What this trial is testing

Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Who this might be right for
Lymphoma, Large B-cell, Diffuse
Chonnam National University Hospital 50
Testing effectiveness (Phase 2)UnknownNCT01990144
What this trial is testing

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL

Who this might be right for
Diffuse Large B-cell Lymphoma
Fondazione Italiana Linfomi - ETS 49
Next Page